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Conclusions: RVP-induced dyssynchronous heart failure could aggravate ﬁbrosis due
to regional heterogeneity of mechanical stress, and it could be partly attenuated by
BiVP, in which mechanical stress-induced EndMT might play pivotal role through
integrin b1 pathway.
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Lipoxin A4 inhibits lipid uptake and oxLDL-induced apoptosis in macrophages
with suppressed biosynthesis in atherosclerotic arteries
Mai Jingting, Yangxin Chen, Qiong Qiu, Woliang Yuan, Jingfeng Wang,
Jingfeng Wang
Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Objectives: To test whether anti-inﬂammatory lipid mediator Lipoxin A4 (LXA4) can
inhibit foam cell formation and macrophages apoptosis, and determine the circulating
and local LXA4 biosynthesis status in atherosclerosis.
Methods: Macrophages apoptosis was evaluated by TUNEL and Annexin V. Mito-
chondrial membrane potential was assayed by JC-1 Assay Kit. Serum and tissue levels
of LXA4 were assayed by ELISA kits.
Results: LXA4 signiﬁcantly suppressed cholesterol uptake genes CD36 and SR-A
expression in a dose-dependent manner in THP-1 macrophages and human monocyte
derived macrophages (from coronary artery disease patients), which could be abol-
ished by LXA4 receptor antagonist BOC-2. Furthermore, LXA4 could inhibit oxLDL-
induced CD36 upregulation. The uptake of Dil-oxLDL and Dil-acLDL as well as
foam cell formation were inhibited under LXA4 stimulation. It was observed that
LXA4 could reduce oxLDL-induced apoptosis in macrophages through inhibiting
caspase-3 activation and restoring mitochondrial membrane potential. Moreover,
cotreatment with LXA4 signiﬁcantly inhibited JNK pathway activated by ox-LDL.
Circulating levels in stable coronary artery disease patients were much higher than that
in nonobstructive patients. Local LXA4 levels were lower but IFN-g levels were
higher in rabbit atherosclerotic vessel walls. In addition, in vitro experiment found that
IFN-g could suppress LXA4 production in activated macrophages and foam cells.
Conclusions: LXA4 could inhibit foam cell formation and oxLDL-induced apoptosis
in macrophages. Increase of circulating LXA4 and decrease of local LXA4 were
observed in atherosclerosis, which indicated that locally but not systematically inad-
equate production of resolution mediators might be the key reason in maintaining
nonresolving inﬂammation in atherosclerosis.
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Association between PPARg Gene Polymorphism Haplotypes and Metabolic
Syndrome in Chinese Population, Case-control and Family-based Study
Yang Lilan, Yang Lilan
The department of cardiology, Taiyuan central hospital, Shanxi
Objectives: We thought to evaluate the possible association between several poly-
morphisms in PPARg gene and metabolic syndrome (MS), using two approaches, a
case-control study and a family-based study.
Methods: Subjects and Measurements Subjects of 605 participated in the study. Case
patients (of MS) of 94 and 131 control subjects participated in a case-control study.
Family-based study included 149 probands and 231 siblings (from 90 families). BMI,
fasting blood sugar (FBS), TC, TG, and HDL-c levels were measured. Genotyping We
detected 7 polymorphisms of PPARg gene, including two prevalence polymorphisms
Pro12Ala (rs1801282) and C161T (rs3856806) and other ﬁve single-nucleotide
polymorphisms (SNP): -553T/C (from the beginning of exon A2), -267T/A (from the
beginning of exon A2), -628G/A (from the beginning of exon 1), rs7650213G/T, and
rs13306747C/G, using a method of RFLP-PCR. Statistical Analysis Differences of
quantitative traits were compared with one way ANOVA. SPSS software 13.0 was
used. Pairwise linkage disequilibrium (LD) expressed in terms of D’ and r2 parameters
and haplotype frequencies were estimated using the THESIAS program. A P val-
ue<0.05 was considered signiﬁcant. The transmission of alleles to affected subjects
with MS or unaffected subjects was analyzed using the transmission disequilibrium
test (TDT) by TRANSMIT software. The proportion T of “overtransmitted” or “high-
risk” alleles from informative parents was estimated by counting informative
transmissions.
Results: Case-Control Study: No signiﬁcant differences could be observed between the
cases and controls of seven polymorphisms (P>0.05). Six common haplotypes were
analyzed. The corresponding ORs of the MS for carriers of the rare allele versus ho-
mozygotes for the common allele of the seven polymorphisms varied from 0.26 to 0.74
(all P>0.05). A lower risk of the MS was observed of haplotype TTCGGCT versus
common homozygote haplotype TTCGGCC. The TTCGGCT haplotype was lower
frequent in MS patients than in control subjects. But it was not signiﬁcant (P¼0.086) .In
pairwise linkage disequilibrium analysis, the polymorphism rs1801282 (all D’>0.5) and
rs7650213 (all D’>0.7) were in linkage disequilibrium with other six polymorphisms.
Family-based Study: In TDT analysis of the pedigree of MS probands of seven
polymorphisms, the patients were more likely to inherit the homozygotes of two poly-
morphisms, C allele (Pro) of rs1801282 and the C allele of rs3856806 (P<0.05). Similar
results were not found in other ﬁve polymorphisms. There was a signiﬁcant lower
transmission of the haplotypes CTGGTCC (P<0.05) in haplotypes analysis of seven
polymorphisms. Other haplotypes were not found overtransmitted or lower transmitted.
Conclusions: In case-control study, seven polymorphisms and their haplotypes of
PPARg are not associated with MS. While in family-based study, two polymorphisms
of PPARg gene, rs1801282 (Pro12Ala) and the rs3856806 (C161T) decrease the risk
of the MS. And the haplotype CTGGTCC of seven polymorphisms can decrease theJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Brisk of MS in MS families. Therefore, PPARg polymorphisms are associated with MS
especially in families.
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Urine may be a preferred source to generate induced pluripotent stem cell-
derived cardiomyocytes for cardiac regenerative medicine
Zhou Yafeng, Yao Jialu, Yang Xiangjun
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Objectives: To test proof-of-principle if human iPSCs can be established by the
transduction of transcription factors (Oc-t4, Sox-2, Klf-4, and c-Myc) into human
adult urine cells and observe whether these iPSCs can be differentiated into
cardiomyocytes.
Methods: We used directed differentiation protocols to derive cardiomyocytes using
serum-free, chemically-deﬁned media supplemented with BMP4, Activin A, bFGF,
VEGF and DKK-1 in stage speciﬁc manner as previously described.
Results: In our study, positive results were obtained from the immunoﬂuorescence
staining of Oct-4, SSEA-4, Nanog, TRA-1-60 and alkaline phosphatase staining of our
putative human iPS cells, which indicated that the reprogrammed human urine cells
were expressing these typical embryonic stem cell (ESC) markers. The putative iPSCs
were ESC-like and showed excellent differentiation potential into lineages derived
from the primary three embryonic germ layers both in vitro and in vivo. Importantly,
after cardiac differentiation from the above iPSCs, spontaneously beating outgrowths
appeared approximately 14 to 21 days in embryoid bodies. Stable action potential
(AP) recorded from spontaneously beating clusters and expression of the cardiac
speciﬁc markers (troponin-T, a- actinin, MLC-2v, MLC-2a and HCN4) clearly
conﬁrmed the differentiation of iPSCs into cardiomyocyte in our study.
Conclusions: With these ﬁndings, we hypothesize that urine may be a preferred
source in a totally noninvasive manner for generating iPS cell-derived cardiomyocytes
for cardiac regenerative medicine.
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The progress of cardiac stem cell study
Lv Anlin
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Objectives: At present the treatment of heart disease have much difﬁculty. The main
causes are due to that drug therapy and percutanenus coronary intervention (PCI) or
coronary artery bypass grafting (CABG) could not increase the number of car-
diomyocytes, so the cardiac function does not enhanced much better. According to this,
the numbers of cardiomyocytes is the key. In a single day the heart failure happens, both
drug therapy and PCI can also not increase the number of cardiomyocytes and the heart
function. With the development about stem cell researches, many studies have testiﬁed
that transplanting of cardiac stem cells can enhanced the ejection fraction (HF) and
cardiac function. The stem cell treatment outstandingly prolongs life-span and improves
the prognosis of the patient suffering from heart failure
Methods: The paper summarized the recent results and clariﬁed the kinds of cardiac
stem cells. The paper overviews the method inducing stem cells into cardiomyocytes.
It also shows the clinic works having been made about cardiac stem cells.
Results: All clinic studies have a signiﬁcative conclusion increasing ejection fraction
of heart. Through that it discusses the modifying technology regulating stem cells.
Conclusions: At last the article reveals the biological organ future of clinic
transplantation.
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MicroRNA-19b Acts as Potential Anti-thrombotic Protector in Coronary Artery
Disease by Targeting Tissue Factor
Li Sufang, Chen Hong
Peking University People’s Hospital
Objectives: Thrombosis plays a critical role in the pathogenesis of acute coronary
events. Microparticles (MPs) are the major carrier of miRNAs in circulation. Tissue
factor (TF), the initiator of extrinsic coagulation cascade, may be regulated by
microRNAs (miRNAs). The aim of this study was to determine the potential role of
miRNAs in regulating gene experession involved in thrombosis in coronary artery
disease (CAD) .
Methods: MiRNA expression proﬁles in the plasma of patients with typical unstable
angina (UA) and angiographically documented CAD compared with individuals with
clinical suspicion of CAD but negative angiography were analyzed using Taqman low-
density miRNA array. Levels of selected ﬁve miRNAs in plasma and plasma MPs were
validated by real-time PCR. The characteristic of endothelial microparticles (EMPs)
from plasma were analyzed by ﬂow cytometry. In endothelial cells (ECs, EA.hy926
cells) and MPs releasd by ECs incubated with TNF-a, the levels of miR-19b were
examined by real-time PCR. The target gene of miR-19b associated with thrombosis
were pridicted by TargetScan and miRanda. Luciferase reporter assays were performed
to conﬁrm the binding of miR-19b to TF mRNA. TF expression induced by TNF-a in
ECs was tested by real-time PCR. ECs were transfected with miR-19b mimic and the
expression of TF were analyzed by real-time PCR and western blotting. Procoagulant
activity of TF was analysed in miR-19b overexpressed ECs.
Results: Amomg 36 differential expressed miRNAs, miR-19b was the most obviously
upregulated one. In UA patients, miR-19b level was upregulated in plasmaasic and Translational Medicine C63
microparticles, and the amounts of EMPs from plasma were increased. In ECs, along
with TF upregulation, miR-19b release and expression were increased stimulated by
TNF-a. Luciferase reporter assays demonstrated that miR-19b bind to TF mRNA.
Overexpression of miR-19b inhibited TF expression and procoagulant activity.
Conclusions: In UA patients, the increasement of miR-19b wrapped in EMPs for
endothelial dysfunction may partialy contributed to the circulating miR-19b elevation.
MiR-19b may play an anti-thrombotic role by inhibiting the expression of TF in ECs.
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Acidic ﬁbroblast growth factor promotes the function of endothelial progenitor
cells through Akt/FOXO3a signaling pathway
Huang Liya, Shuyan Chen
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Objectives: Endothelial progenitor cells (EPCs) contribute to angiogenesis and acidic
ﬁbroblast growth factor (FGF1) gene transfer enhances EPC function. The Forkhead box
O transcription factors (FOXOs) play an important role in the regulation of various
cellular processes and EPCs mainly express FOXO3a. Here, we aimed to determine
whether FGF1 promotes EPC function through Akt/FOXO3a signaling pathway.
Methods: EPCs were cultured from human peripheral blood and transduced with
adenoviral vectors expressing a non-phosphorylatable, constitutively active mutant of
FOXO3a (Ad-TM-FOXO3a) and the GFP transgene (Ad-GFP) used as control. The
Ad-GFP group treated with FGF1 showed the functional improvement including cell
survival, proliferation, migration and tube formation, whereas the above promoting
effects were reversed after adding Akt inhibitor.
Results: The Ad-TM-FOXO3a group showed the reduced functionality compared with
the control and failed to make the functional recovery after FGF1 treatment. Western
blotting revealed that FGF1 made EPC functional enhancement through upregulating
the phosphorylation of Akt and FOXO3a which could be suppressed by Akt inhibitor.
Conversely, FGF1 failed to rescue EPCs transduced with Ad-TM-FOXO3a from
dys-function because the mutant FOXO3a were not phosphorylated by Akt.
Conclusions: FGF1 promoting EPC function is mediated through Akt/FOXO3a
signaling pathway. The molecular mechanism of EPC functional improvement we
initially explored may provide new ideas for the future to enhance the EPC angiogenic
effect and optimize the EPC transplantation therapy.
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Altered Serum MicroRNAs as Novel Diagnostic Biomarkers for Atypical
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Objectives: Atypical coronary artery disease (ACAD) is characterized by atypical
angina pectoris or silent myocardial ischemia. However, conventional diagnostic
techniques are insufﬁcient to identify this subtype of coronary atherosclerotic pa-
thology, and speciﬁc and sensitive markers for diagnosing ACAD are still currently
lacking. The aim of the present study is to identify a novel serum miRNA expression
proﬁle of ACAD patients and evaluate its clinical diagnostic value.
Methods: We enrolled 122 patients who were diagnosed with ACAD and 44 age-
matched controls in this study. We examined the levels of a subset of serum miRNAs
in both ACAD and control samples. In addition, we sought to predict the potential
target genes of the altered miRNAs using bioinformatics methods.
Results: By using TaqMan low density array technology followed by conﬁrmation with
quantitative real-time PCR (qRT-PCR), we identiﬁed four miRNAs including miR-
487a, miR-502, miR-208 and miR-215 that were signiﬁcantly increased, and one
miRNA, miR-29b which was signiﬁcantly decreased in ACAD patients compared with
normal subjects (P< 0.05). The area under the ROC curve (AUC) for the ﬁve miRNAs
ranged from 0.670 to 0.876 (P< 0.05), and their panel (0.885) was signiﬁcantly higher
than that of hsTnI (0.627). In addition, target gene prediction showed that these ﬁve
altered miRNAs are involved in affecting various aspects of cardiac or vascular
remodeling, especially in the pathway involving inﬂammation and ﬁbrosis.
Conclusions: Our ﬁndings indicate that the ﬁve altered serum miRNAs could be
novel non-invasive biomarkers for ACAD and may also represent potential thera-
peutic targets for atherosclerosis and myocardial ischemia.
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Protective effects and mechanism of trimetazidine on myocardial structure
damaged by pyran adriamycin
Li Jie, Zhang Liling, Jin junxiang, Li Qun
The ﬁrst hospital of Jilin University
Objectives: To explor the effects of trimetazidine on myocardial structure damaged
by pyran adriamycin and to clarify the protection and mechanism of trimetazidine on
damaged myocardial structure induced by pyran adriamycin.C64 JACC Vol 64/16/Suppl C j OctobMethods: 36 Wistar rats were randomly divided into control group, model group and
treatment group. Rats in model group and treatment group were injected pyran
doxorubicin 2.5mg/kg (concentration 2mg/ml) by the vena caudal once a week.
Control group were injected equivalent normal saline in a coordinative control for 6
weeks. Rats in treatment group were intragastric infuse trimetazidine 5.4mg/kg/d one
day before making the model. Control group, model group were injected equivalent
normal saline in a coordinative control for 8 weeks. At the end of the experiment,
index of heart mass of rats and myocardial enzymes of serum were measured. Systolic
and diastolic function were detected with echocardiography. The myocardium tissue
were detected by light microscope and electron microscope.
Results: Compared with model group, the level of myoglobin, troponin and alanine
transaminase (ALT) in treatment groupwere decreased (P<0.05). Index of heart mass in
treatment group is lower than that in model group and nearly the level of control group.
Compared with control group, EF and FS in model group decreased (P<0.01) and
LVIDD, LVIDS in creased (P<0.05). EF and FS in Group C is larger than that in Group
B (P<0.05), LVIDS, LVIDD in treatment group is lower than model group (P<0.05).
Under the lightmicroscope observation, inmodel groupmyocardial arranged disorderly,
severely damaged structure, multiple visibl emyocardial, myoﬁlament dissolved, frac-
ture, while in treatment group myocardial arranged in order, structure was nearly inte-
grated, partial dissolution, fracture. Under the electronmicroscope observation, inmodel
group myocardial muscle bundle dissolved fractured, disappeared, mitochondria
decreased, cytoplasmic matrix cavitation, while in treatment group, arrangement of
cardio myocytes sarcomeres in tow, local myoﬁlaments reduced slightly, surrounding
mitochondria were oval and arranged in parallel between the muscle bundles.
Conclusions: Trimetazidine can protect the damaged cardiomyocytes and improve the
cardiac function caused by pyran adriamycin, and its mechanism may be related to
decrease the injury of mitochondria and myocytes
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Prognostic Value of Mean Platelet Volume to Platelet Count Ratio and White
Blood Cell Count in Predicting the Survival in Acute Aortic Dissection
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Objectives: Recent evidence indicates that platelet indices and white blood cell
(WBC) are associated with the prognosis of patients with acute aortic dissection (AD).
However, there have been no systematic investigations on the utility of baseline mean
platelet volume (MPV) to platelet count (PC) ratio (MPV/PC ratio) and WBC for
predicting the survival of acute AD. The present study was designed to examine
whether the MPV/PC ratio and WBC could predict mortality in acute AD
Methods: Baseline clinical details and hematologic parameters were obtained pro-
spectively in 272 acute AD patients consecutively admitted to a single medical center.
The levels of MPV, PC and WBC were determined after their initial admission and
evaluated, in concert with follow-up patient survival data, to determine if the MPV/PC
ratio and WBC could predict mortality. Between initial measurement and follow-up
(medium time: 570 (11-1222.5) days)
Results: Increased levels of plasma MPV/PC ratio (6.3513 (4.6439-8.8730) versus
5.3939 (4.068-6.7415), P<0.001) and WBC (11.90 (8.85-16.03) vs 9.91 (7.46-13.05),
P<0.001)were found indead patients comparedwith those survivedduring the follow-up.
Multivariable analysis showed that MPV/PC ratio (P¼0.014, OR¼1.179, 95% CI: 1.034
to 1.344) and WBC (P¼0.011, OR¼1.106, 95% CI: 1.024 to 1.195) was an independent
predictor for all-cause mortality during follow-up, respectively. The areas under receiver
operating characteristic (ROC) curves of MPV/PC ratio and WBC were 0.618 (95% CI:
0.542 to 0.694) and 0.625 (95% CI: 0.553 to 0.698) for predicting follow-up mortality,
with a sensitivity of 39.8%, speciﬁcity of 88.1%, cut-off valueof 7.55197102fL/ (109/L)
and a sensitivity of 52.7%, speciﬁcity of 68.9%, cut-off value of 11.53109/L, respec-
tively, While the areas under ROC curves of combination WBC and MPV/PC ratio was
0.674 (95%CI: 0.603 to 0.745) with a sensitivity of 39.8%, speciﬁcity of 88.1%. Kaplan-
Meier analysis and log-rank test revealed signiﬁcant survival differences between patients
with a MPV/PC ratio<7.55197102fL/ (109/L) and a MPV/PC ratio7.55197102fL/
(109/L) (P<0.001) and with a WBC <11.53109/L and a WBC 11.53109/L
(P<0.001). Subgroup analysis showed MPV/PC ratio had prognostic value for mortality
in patients with type A (P<0.001), surgery (P¼ 0.007) and only medication treatment
(P<0.001), no predictive value were found in patients with type B (P¼0.410) and
endovascular treatment (P¼ 0.822) patients, while prognostic value ofWBC formortality
was found in patients with type A (P¼0.004) and only medication treatment (P¼0.004).
Conclusions: the elevated MPV/PC ratio and WBC were important risk factors and
independently associated with mortality of patients with acute AD. These patients may
beneﬁt more from surgical intervention and endovascular treatment.
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Berberine attenuates cardiac dysfunction, ﬁbrosis, inﬂammatory in diabetic
cardiomyopathy
Guo-Hua Li1, Feng-Hao Geng1, Xiang-Yang Qin2, Ming-Qing Dong3, Yuan Zhang1,
Feng Gao1, Ling Dong1
1Department of Physiology, The Fourth Military Medical University, Xi’an 710032,
China, 2Department of Chemistry, School of Pharmacy, The Fourth Military Medical
University, Xi’an 710032, China, 3Department of Pathophysiology, The Fourth
Military Medical University, Xi’an 710032, Chinaer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
